ZAM
CVS icon

Zevin Asset Management’s CVS Health CVS Stock Holding History

Zevin Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-17,819
Closed -$1.45M – 134
2017
Q3 		$1.45M Buy
17,819
+319
+2% +$25.2K 0.34% 57
2017
Q2 		$1.41M Sell
17,500
-920
-5% -$72.6K 0.36% 56
2017
Q1 		$1.45M Sell
18,420
-48,520
-72% -$3.87M 0.37% 52
2016
Q4 		$5.28M Sell
66,940
-22,163
-25% -$1.79M 1.38% 25
2016
Q3 		$7.93M Sell
89,103
-93,049
-51% -$8.78M 2.56% 12
2016
Q2 		$17.4M Buy
182,152
+1,575
+0.9% +$157K 4.84% 4
2016
Q1 		$18.7M Buy
180,577
+1,103
+0.6% +$107K 5.3% 3
2015
Q4 		$17.5M Buy
179,474
+86,340
+93% +$8.46M 4.62% 3
2015
Q3 		$8.99M Buy
93,134
+460
+0.5% +$48.4K 2.62% 8
2015
Q2 		$9.72M Buy
92,674
+90,615
+4,401% +$9.26M 2.59% 7
2015
Q1 		$213K Buy
+2,059
New +$208K 0.06% 131

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Zevin Asset Management's CVS Position: Q4 2017 in Review

Zevin Asset Management sold out of CVS Health (CVS) in Q4 2017, closing a stake of 17,819 shares — an estimated $1.45M sold.

Zevin Asset Management first reported a position in CVS in Q1 2015 and held it in 11 quarters. The position peaked at $18.7M in Q1 2016. 1,598 funds tracked by Wall St. Rank hold CVS as of Q4 2017.

  • Zevin Asset Management reported no remaining CVS Health position as of Q4 2017 after selling out during the quarter.
  • Zevin Asset Management sold 17,819 CVS Health shares in Q4 2017, an estimated $1.45M.
  • Zevin Asset Management first reported a position in CVS Health in Q1 2015 and held it in 11 quarters.
  • Zevin Asset Management's CVS Health position peaked at $18.7M in Q1 2016.
  • 1,598 funds tracked by Wall St. Rank held CVS Health as of Q4 2017.

Based on Zevin Asset Management's 13F filing for Q4 2017, filed 5 Feb 2018.